Synopsis
Urotensin II (UII) and its paralog urotensin II-related peptide (URP) are two vasoactive neuropeptides whose respective central actions are currently unknown.
Here, we have compared the mechanism of action of URP and UII on cultured in astrocytes was obtained but sole the effect of UII was significantly reduced by PTX, although BRET experiments revealed that both UII and URP recruited G o protein.
Finally, UII exerted a dose-dependent mitogenic activity on astrocytes, but not URP.
Therefore, we described that URP and UII exert not only similar but also divergent actions on astrocyte activity, UII exhibiting a broader range of activities at physiological peptide concentrations.
human [3] . UII and URP share a fully conserved C-terminal cyclic hexapeptide CFWKYC core that plays a major role for the biological activity of the peptides [4] . The cyclic region of UII and URP exhibits some structural similarities to that of somatostatin ( Fig. 1 ) and it has recently been found that the genes encoding these three neuropeptides originate from a common ancestor [5] .
The mRNAs encoding the UII and URP precursors have been localized both in the brain and in peripheral organs [3] . In the rat and mouse central nervous system (CNS), the UII and URP genes are primarily expressed in subpopulations of motoneurons located in discrete brainstem nuclei and in the ventral horn of the spinal cord [6, 7] . In the human brain, high levels URP mRNA are also present in the hippocampus and thalamus [3] . It has recently been shown that a mature form of UII in the rat brain could only imply atypical clivage sites in prepro-UII, and that URP might be the sole UII-immunoreactive substance present in the rodent brain [8] .
The biological action of UII and URP are mediated through activation of a common G protein-coupled receptor originally called GPR14 [3, 9] and now renamed UT [2] . In UT-transfected CHO and HEK293 cells, UII stimulates the phospholipase C pathway and causes an increase in cytosolic calcium concentration ([Ca 2+ ] c ) [10] . UII also exerts mitogenic activity in UT-transfected cells and in vascular smooth muscle cells expressing native UT [10, 11] .
In the CNS, UT mRNA has been detected in motoneurons of the spinal cord in mouse [12] and rat [13] as well as in the thalamus, superior occipital gyrus and substantia nigra in human [9] . Previous studies have shown that central administration of UII modulates cardiovascular, locomotor, behavioral and endocrine functions [14, 15] .
Although URP has been proposed as the sole endogenous ligand for urotensinergic receptors in the brain [3] , little is known regarding the central activities of URP.
It is now clearly established that astroglial cells release various neuroactive compounds [16] including the gliopeptides endozepines. Endozepines were originally characterized as endogenous ligands for benzodiazepine receptors [17] . All endozepines characterized so far derive from an 86-amino-acid precursor called diazepam-binding inhibitor (DBI) which generates several biologically active fragments, notably the octadecaneuropeptide (ODN, DBI [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] ) [18] . The release of endozepines from astrocytes is regulated by several neuropeptides such as pituitary adenylate cyclase-activating polypeptide (PACAP) and somatostatin [19, 20] .
The expression of UII and its receptor has been previously reported in a human glioblastoma cell line [21] and the presence of functional UT has been demonstrated in astrocytes [22, 23] . In astroglial cells, UII specifically binds two affinity sites, stimulates polyphosphoinositides (PIP) metabolism and causes a robust increase in [Ca 2+ ] [22, 24] . Up to now, nothing is known regarding the mechanism of action of URP on native cells, and the relevance for the existence of a redundant peptide for a unique UT receptor remains unexplored. In the present study, we have characterized functional binding sites for URP on rat cortical astrocytes and compared the effects of URP with those of UII on electrophysiological activity, endozepine release, Ca
2+
, PIP
turn-over and cell proliferation.
Experimental
Reagents URP (ACFWKYCV), rat UII (UII, pQHGTAPECFWKYCI) and rat octadecaneuropeptide ODN (diazepam-binding inhibitor 33-50, DBI 33-50 ) were synthesized by the solid phase methodology on a Pioneer PerSeptive Biosystem peptide synthesizer (Applera France, Courtaboeuf, France) using the standard manufacturer's procedures as previously described [25] . All peptides were purified (> 98%) on a 2.2 X 25-cm Vydac C 18 column (Alltech, France) and characterized by MALDI-TOF MS on a Voyager DE-PRO mass spectrometer (Applera-France).
Glutamine, N-2 hydroxyethylpiperazine-N'-2-ethane sulfonic acid (HEPES), the antibiotic-antimycotic solution and bovine γ-globulins were purchased from Invitrogen (Cergy-Pontoise, France ] c measurements), 35-mm dishes (for measurement of PIP turnover) and in 60-mm dishes (for measurement of endozepine release). The purity of the cultures was assessed by GFAP immunostaining which showed that enriched cultures contained > 98% astrocytes [22] .
Binding studies A c c e p t e d M a n u s c r i p t
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Electrophysiological experiments
Electrophysiological recordings were performed at room temperature (22°C) on 2-4 DIV cultured astrocytes seeded on glass coverslips using the standard A c c e p t e d M a n u s c r i p t
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Statistical significance of differences was determined by using the one-way ANOVA followed by a Dunnett's post hoc test or the non-parametric Friedman's test.
Results

Binding characteristics of URP on cultured rat astrocytes
Competition experiments performed with [ 125 I]UII (0.2 nM) as a tracer and unlabelled UII (1 pM-1 µM) generated a biphasic curve with a Hill coefficient of 0.81 ± 0.06 ( Fig. 2A) . In contrast, graded concentrations of unlabeled URP (1 pM-1 µM) generated a monophasic displacement curve with a Hill coefficient close to 1.
Statistical analysis of the competition experiments using the F-test showed that data best fitted with a two-site model (p < 0.05) and the calculated dissociation constants for the high-(K 1 ) and low-affinity (K 2 ) sites were 0.31 ± 0.12 and 32.9 ± 18.7 nM for UII and with a one-site model (p < 0.05) yielding a dissociation constant for a highaffinity (K) site of 1.62 ± 0.74 nM, for URP ( Fig A c c e p t e d M a n u s c r i p t
a decrease of the input resistance. The majority of responding astrocytes remained in a depolarized state during the washout period (Fig. 3A) . The amplitudes of membrane depolarization induced by URP at concentrations of 10 nM (9.6 ± 2.6 mV, n = 5) and 100 nM (16.6 ± 4.3 mV, n = 8) were very similar to those evoked by UII (10 nM, 9 ± 4 mV, n = 3; 100 nM, 15.5 ± 2.8 mV, n = 12, Fig. 3B ).
Graded concentrations of URP (1 ] c increase (peak) followed by a sustained response (plateau) [22] . Preincubation of astrocytes with the G i/o protein inhibitor pertussis toxin (PTX, 0.2 µg/mL, 18 h) did not affect the Ca 2+ responses induced by both peptides (Fig. 4A) . In contrast, the URP-and UII-induced Ca A c c e p t e d M a n u s c r i p t
Licenced copy. Copying is not permitted, except with prior permission and as allowed by law. (Thr, 50 U/mL), the BRET signal is not modified (Fig. 7A ). In contrast, kinetic analysis showed that UII and URP (10 µM, each) injection provoked BRET signal decrease between G αo and G γ2 subunits, which occurred rapidly and persisted for more than one minute (Fig. 7B) . In order to control the specificity of the UT-G o coupling,
BRET signal was measured on HEK293-PAR-1 in the presence of Thr, UII and URP.
In these cells, Thr induced BRET decrease whereas URP and UII failed to activate G protein dissociation (Fig. 7C ).
Effect of URP and UII on cell viability/proliferation in cultured rat astrocytes 2-DIV cells (non synchronized) were cultured in complete medium additionned with FBS and then incubated in a FBS-free medium containing URP or UII (10 nM, each). Cell viability was measured 24 h later by using WST-1 assay, allowing detection of mitochondrial activity related to the number of viable cells. Fig. 8A showed that URP failed to affect the cell viability whereas UII stimulated by 132.7% the astrocyte growth. PACAP (10 nM), interleukin-1 (IL-1β, 10 ng/mL) and endothelin-1 (ET-1, 10 nM) were also tested as positive controls and gave rise respectively to 126.3, 169.3 and 171.1% increase (Fig. 8A) . The dose-response effects of URP and UII on cell growth were also investigated in non-synchronized (WST-1, A c c e p t e d M a n u s c r i p t
( Fig. 8B ) or 48 h-treatment ( Fig. 8C ) with graded concentrations of URP failed to significantly modify the rate of cell growth. In contrast, UII induced a dose-dependent cell growth, yielding an EC 50 value of 2.37 ± 0.02 nM, and a maximum stimulatory effect of 132.9 ± 7.0% at 1 µM (Fig. 8B ) in non-synchronized cultures, and evoked a significant cell number increase (120.1 ± 2.9%) at 0.1 µM in synchronized conditions (Fig. 8C) .
Discussion
Although the cardiovascular effects of the urotensinergic system are now well characterized, little is known concerning the roles of UII and URP in the CNS.
Immunohistochemical studies have shown the presence, in the rat brain, of UT-like immunoreactivity in GFAP-positive cells within the brainstem, hypothalamus and thalamus [23] . In agreement with these observations, we have recently demonstrated that rat cortical astrocytes express UT mRNA, contain the UT protein, and exhibit very high-and high-affinity UII binding sites [22] . In these cells, UII specifically activates a PLC/PIP/Ca 2+ transduction pathway, via both PTX-sensitive and -insensitive G proteins [22] . The identification of a UII paralog, URP, which apparently exhibits the same pharmacological characteristics as UII [3] , raises the question as to whether URP functions as a UII backup in the brain. In the present study, we have looked for the existence of URP binding sites in cultured rat astrocytes and we have compared the mechanisms of action of URP and UII on astroglial cell activity. A c c e p t e d M a n u s c r i p t
were 10 times more potent than human UII in competing with [ 125 I]UII at recombinant UT [3, 32] , suggesting that the N-terminal segment of UII decreases the affinity of the peptide for its receptor. It has previously been shown that cultured rat astrocytes express UT mRNA and that UT-like immunoreactivity is located at the plasma membrane of astroglial cells [22, 23] . Thus, the present study suggests that the high affinity site bound by URP actually correspond to UT. The cyclic hexapeptide core of UII and URP exhibits substantial similarities with the biologically active region of somatostatin-14 ([33, 34]; Fig. 1 ) and UT shares sequence identity with somatostatin receptors (sst) [35] . In spite of these relatively high degree of sequence homologies, UII exhibits very low affinity for somatostatin receptors (sst1, sst2 and sst4) either transfected in cell lines [36] or naturally expressed in astrocytes [20, 22, 37] ] c levels and proliferation of recombinant sst-2 expressing CHO cells [38] . Together, it is suggested that shorter urotensinergic peptides in their N-terminal sequence ( Fig. 1 ; human UII and URP) were more potent than longer UII (rat UII) in competing for the high affinity UII binding site UT, and also acquired the ability to bind sst.
Astrocytes have long been considered as non-excitable support of neuronal cells in the brain. It is now well established that astroglial cells express functional channels
and receptors enable to sense synaptic transmission [39] . In addition, astrocytes participate in neuronal functioning not only via feeding and structural support, but also through release of gliotransmitters such as glutamate, D-serine, ATP, cytokines or endozepines [16] . Application of URP or UII in the vicinity of astrocytes in culture induced a slow in onset membrane depolarization accompanied by a decrease of the input resistance. It has also been demonstated that UII depolarizes nervous cells on A c c e p t e d M a n u s c r i p t
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type channels by nifedipine and ω-conotoxine GVIA, respectively. These observations suggest that high level of UT activation leads to the recruitement of both extra-and A c c e p t e d M a n u s c r i p t
involved in the UII-induced natriuretic peptide release from rat atria [56] and the MAPK pathway appeared clearly implicated in several UII processes including vascular and airway smooth muscle cell proliferation and migration, fibroblast proliferation or cardiomyocyte hypertrophy [57] , we hypothesize that a UT-G i/o -PI3K-PTX sensitive pathway mainly activated by UII, and in a less extent by URP, might thus be involved in Ca
2+
-independent astrocyte activities.
Pathological processes in the brain are usually accompagnied by a significant astrocyte proliferation referred as to astrogliosis. Here, we demonstrated that UII, but not URP, significantly stimulated rat cortical astrocyte proliferation. Numerous studies have demonstrated that vasoactive peptides or interleukins play important roles in astrogliosis [58] . Thus, we demonstrated that in the same set of experiments, PACAP and ET-1 tested at the same concentration than URP and UII, as well as IL1-β, also markedly increase cell growth. Moreover, graded concentrations of URP and UII were tested on either non synchronized or synchronized cells, and the data demonstrate the existence of a UII-specific dose-dependent increase of cell viability. A similar activity for UII has already been observed on rat vascular smooth muscle cells [11] , on human endothelial cells [59] , and on UT transfected CHO cells [10] . Considering that URP has been shown to activate porcine sst2 [36] , we proposed that the absence of mitogenic role of URP would be linked to its ability to bind sst expressed by astrocytes, as sst2 [37, 20] . It is conceivable that concomitant UT-G q and sst2-G i recuitements by URP may i) also lead to [Ca 2+ ] c increase and/or ii) antagonize some specific very high-affinity UII/UT-mediating transduction pathways involved in cell proliferation.
In conclusion, the present study has demonstrated for the first time that URP and UII activate functional receptors in native rat cortical astrocytes, exhibiting similar and distinct ways of action. URP and UII bind a high affinity site that exhibits the pharmacological characteristics of UT, mediating cell depolarization, endozepine release and PLC-dependent Ca 2+ mobilization through intra-(IP 3 receptor) and extracellular (T-type Ca 2+ channels) pools (Fig. 9) . Ca 2+ entry though T-type channels appears essential for IP 3 -induced Ca 2+ increase whereas Ca 2+ release from intracellular stores induces Ca 2+ release. In addition, UII, and in a less extent URP, are able A c c e p t e d M a n u s c r i p t
to activate a higher affinity site coupled to a PTX-sensitive G protein, that would mediate an hypothetical PI3K activation, relaying an important physiological astrocyte behavior, i.e. cell proliferation (Fig. 9) . Finally, URP, but not UII, may bind sst expressed in rat astrocytes whose activation would mimick the UT-Ca 2+ coupling and/or counteract the mitogenic role of UT (Fig. 9) . These data provide the first understanding of the involvement of the two vasoactive peptides UII and URP in nerve cell activity, stressing the specific role of UII in the (patho)physiology of astrocytes.
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